Authors:
Keefe, KA
Schell, MJ
Brewer, C
McHale, M
Brewster, W
Chapman, JA
Rose, GS
McMeeken, DS
Lagerberg, W
Peng, YM
Wilczynski, SP
Anton-Culver, H
Meyskens, FL
Berman, ML
Citation: Ka. Keefe et al., A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia, CANC EPID B, 10(10), 2001, pp. 1029-1035
Citation: Tc. Krivak et al., Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: Comparison of treatment and survival, GYNECOL ONC, 83(1), 2001, pp. 89-94
Authors:
Krivak, TC
Rose, GS
McBroom, JW
Carlson, JW
Winter, WE
Kost, ER
Citation: Tc. Krivak et al., Cervical adenocarcinoma in situ: A systematic review of therapeutic options and predictors of persistent or recurrent disease, OB GYN SURV, 56(9), 2001, pp. 567-575
Authors:
Krivak, TC
McBroom, JW
Seidman, J
Venzon, D
Crothers, B
MacKoul, PJ
Rose, GS
Carlson, JW
Birrer, MJ
Citation: Tc. Krivak et al., Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: A poor prognostic factor, CANCER RES, 61(11), 2001, pp. 4382-4385
Authors:
Cloven, NG
Re, A
McHale, MT
Burger, RA
DiSaia, PJ
Rose, GS
Campbell, KCM
Fan, H
Citation: Ng. Cloven et al., Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer, ANTICANC R, 20(6B), 2000, pp. 4205-4209
Authors:
Krivak, TC
Retherford, B
Voskuil, S
Rose, GS
Alagoz, T
Citation: Tc. Krivak et al., Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ, GYNECOL ONC, 77(2), 2000, pp. 334-335
Authors:
Moore, MM
Tewari, K
Rose, GS
Fruehauf, JP
DiSaia, PJ
Citation: Mm. Moore et al., Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient, GYNECOL ONC, 73(3), 1999, pp. 452-454